MustGrow Biologics Corp.
MGROF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $789 | $2,849 | $3,782 | $119 |
| % Growth | -72.3% | -24.7% | 3,082.5% | – |
| Cost of Goods Sold | $648 | $2,255 | $3,241 | $94 |
| Gross Profit | $141 | $595 | $541 | $25 |
| % Margin | 17.9% | 20.9% | 14.3% | 21.3% |
| R&D Expenses | $111 | $81 | $122 | $251 |
| G&A Expenses | $1,659 | $512 | $840 | $665 |
| SG&A Expenses | $2,203 | $1,194 | $1,580 | $785 |
| Sales & Mktg Exp. | $544 | $683 | $740 | $120 |
| Other Operating Expenses | $249 | $292 | $315 | $232 |
| Operating Expenses | $2,563 | $1,568 | $2,017 | $1,268 |
| Operating Income | -$2,422 | -$973 | -$1,475 | -$1,243 |
| % Margin | -306.9% | -34.2% | -39% | -1,046% |
| Other Income/Exp. Net | -$8 | -$116 | -$165 | $30 |
| Pre-Tax Income | -$2,430 | -$1,089 | -$1,640 | -$1,213 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$1,744 | -$1,089 | -$1,640 | -$1,213 |
| % Margin | -221% | -38.2% | -43.4% | -1,020.7% |
| EPS | -0.032 | -0.021 | -0.032 | -0.016 |
| % Growth | -52.6% | 34.3% | -95.1% | – |
| EPS Diluted | -0.032 | -0.021 | -0.032 | -0.016 |
| Weighted Avg Shares Out | 54,707 | 52,128 | 51,641 | 51,641 |
| Weighted Avg Shares Out Dil | 54,707 | 52,128 | 51,641 | 51,641 |
| Supplemental Information | – | – | – | – |
| Interest Income | $2 | $4 | $14 | $25 |
| Interest Expense | $7 | $53 | $43 | $0 |
| Depreciation & Amortization | $13 | $13 | $11 | $1,073 |
| EBITDA | -$2,407 | -$1,023 | -$1,587 | -$170 |
| % Margin | -305% | -35.9% | -42% | -143.1% |